Molecular modelling analysis of retro-inverso (RI) peptides in association with MHC class II molecules

سال انتشار: 1384
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 2,033

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

NBCI04_231

تاریخ نمایه سازی: 30 دی 1386

چکیده مقاله:

In an effort to understand the different biological properties of natural L and retro-inverso (RI) peptides in complex with MHC class II molecules, we analysed the molecular interaction patterns and conformational behaviour of the RI-peptides with MHC class II molecules. By homology to the crystal structure of the human leukocyte antigen DR1 (HLA-DR1) complexed with influenza haemagglutinin epitope (HA) a model for the bovine leukocyte antigen BoLA-DRB3*0201 was built. The foot and mouth disease virus (FMDV) derived peptides with strongest MHC binding and T cell proliferative capacity were selected for modelling and minimisation. The non-bonded interaction energy between MHC and ligand was slightly less in RI-complexes when compared with L complexes. However, the internal bonded energy of the RI-peptides showed considerable conformational strain. Furthermore, we postulated that the RI-peptides should be able to adopt a reversed orientation in the groove in order to mimic their natural L-counterparts. To investigate the hypothesis that, RI-peptides might prefer their secondary structure in a right handed (RH) polyproline twist, rather than the left handed (LH) polyproline type II twist, we forced them into a RH twist and analysed their interaction patterns. Interestingly, these data support our idea that, the RH conformation is the preferred conformation for RI-peptides. This however, disrupts the mimicry and abolishes most interactions with MHC. This may explain our earlier observation that, RI-peptides were not able to mimic their parent L peptides in terms of interaction with MHC class II molecules.

کلیدواژه ها:

نویسندگان

Alireza Haghparast

Immunology Section, Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad

Ed E Moret

Department of Medicinal Chemistry, Utrecht Institute for Pharmaceutical Sciences, Faculty of Pharmacy, Utrecht University.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • .WcFarland, B. J., C. Beeson, and A. J. Sant. 1999. ...
  • .Weziere, C., M. Viguier, H. Dumortier, R. Lo-Man, C. Leclerc, ...
  • .Wikko, S., K. Roed, S. Schmutz, and L. Andersson. 1999. ...
  • .Worgan, B. P., J. M. Scholtz, M. D. Ballinger, I. ...
  • .Wurthy, V. L., and L. J. Stern. 1997. The class ...
  • O stankovitch, M., G. Guichard, F. Connan, S. Muller, A. ...
  • Petit, M. C., N. Benkirane, G. Guichard, A. P. Du, ...
  • Russell, G. C., C. J. Davies, L. Andersson, S. A. ...
  • Saito, N. G., and Y. Paterson. 1997. Contribution of peptide ...
  • Scherf, T., R. Hiller, F. Naider, M. Levitt, and J. ...
  • Shemyakin, M. M., Y. A. Ovchinnikov, and V. T. Ivanov. ...
  • Siligardi, G., and A. F. Drake. 1995. The importance of ...
  • Stern, L. J., J. H. Brown, T. S. Jardetzky, J. ...
  • Verdoliva, A., M. Ruvo, G. Cassani, and G. Fassina. 1995. ...
  • Vriend, G. 1990. WHAT IF: a molecular modeling and drug ...
  • Wermuth, J., S. L. Goodman, A. Jonczyk, and H. Kessler. ...
  • Wilson, I. A., and R. L. Stanfield. 1994. Antibo dy-antigen ...
  • نمایش کامل مراجع